Keyword Analysis & Research: nutcracker therapeutics
Keyword Research: People who searched nutcracker therapeutics also searched
Search Results related to nutcracker therapeutics on Search Engine
-
Nutcracker Therapeutics | Home | Cracking the RNA Tx code
https://www.nutcrackerx.com/
WEBCracking the code for RNA therapeutics. Nutcracker Therapeutics is an early-stage company that is pioneering a revolutionary therapeutic development and manufacturing platform designed to enable the advancement of RNA-based treatments for as many diseases as possible, as fast as possible. Learn More.
DA: 41 PA: 65 MOZ Rank: 42
-
Accelerating RNA Tx Development | Nutcracker
https://www.nutcrackerx.com/pipeline/
WEBNutcracker Therapeutics is an early-stage company that is pioneering a revolutionary therapeutic development and manufacturing platform designed to enable the advancement of RNA-based treatments for as many diseases as possible, as fast as possible.
DA: 84 PA: 23 MOZ Rank: 18
-
Company | Nutcracker
https://www.nutcrackerx.com/about/
WEBNutcracker Therapeutics is an RNA medicines company that has combined the power of advanced engineering with high-precision biosynthesis to create a complete RNA platform. We have initiated multiple development programs, in collaboration with clinical investigators, at leading medical institutions.
DA: 36 PA: 9 MOZ Rank: 14
-
Nutcracker Therapeutics Raises $167 Million in Series C …
https://www.businesswire.com/news/home/20220314005099/en/Nutcracker-Therapeutics-Raises-167-Million-in-Series-C-Financing-to-Advance-its-mRNA-Therapeutics-and-First-of-its-Kind-Biochip-based-Manufacturing-Platform
WEBMar 14, 2022 · EMERYVILLE, Calif.-- ( BUSINESS WIRE )--Nutcracker Therapeutics, Inc., a biotech company developing RNA therapeutics using its proprietary biochip-based manufacturing platform, today...
DA: 44 PA: 13 MOZ Rank: 58
-
Nutcracker Therapeutics | LinkedIn
https://www.linkedin.com/company/nutcracker-therapeutics
WEBNutcracker Therapeutics is developing mRNA therapeutics and a novel GMP manufacturing platform. View all 128 employees. About us. Nutcracker Therapeutics is an RNA therapeutics company...
DA: 32 PA: 41 MOZ Rank: 3
-
Nutcracker Therapeutics Announces $60 Million Series B …
https://www.prnewswire.com/news-releases/nutcracker-therapeutics-announces-60-million-series-b-financing-to-advance-mrna-therapeutics-produced-on-transformational-biochip-based-acorn-platform-301136243.html
WEBEMERYVILLE, Calif., Sept. 23, 2020 /PRNewswire/ -- Nutcracker Therapeutics, Inc., a company developing and producing mRNA therapeutics on its proprietary, microfluidic, biochip-based platform,...
DA: 98 PA: 94 MOZ Rank: 1
-
Nutcracker Therapeutics Reports Strong Anti-Tumor Responses …
https://www.businesswire.com/news/home/20221111005057/en/Nutcracker-Therapeutics-Reports-Strong-Anti-Tumor-Responses-of-Lead-mRNA-Immunotherapy-in-Preclinical-Data-Presented-at-SITC-Annual-Meeting-2022
WEBNov 11, 2022 · Nutcracker Therapeutics, Inc. is an RNA therapeutics company that has combined the power of advanced engineering with high-precision biosynthesis to deploy a complete RNA platform that...
DA: 57 PA: 44 MOZ Rank: 67
-
Nutcracker Therapeutics Demonstrates Anti-tumor Responses of …
https://www.businesswire.com/news/home/20231107572923/en/Nutcracker-Therapeutics-Demonstrates-Anti-tumor-Responses-of-Two-Preclinical-mRNA-Drug-Candidates-at-2023-SITC-Annual-Meeting
WEBNov 7, 2023 · Nutcracker Therapeutics, Inc. is an RNA therapeutics company that has combined the power of advanced engineering with high-precision biosynthesis to deploy a complete RNA platform that...
DA: 68 PA: 7 MOZ Rank: 91
-
mRNA printers kick-start personalized medicines for all
https://www.nature.com/articles/s41587-022-01430-y
WEBAug 9, 2022 · Nutcracker Therapeutics is building a GMP capability into its miniaturized ‘GMP-in-a-box’ platform for manufacturing low-volumes of therapeutic mRNA molecules. Its focus is on low-volume and...
DA: 17 PA: 53 MOZ Rank: 26
-
Nutcracker Therapeutics raises $167m to advance mRNA biochip …
https://www.biopharma-reporter.com/Article/2022/03/17/nutcracker-therapeutics-raises-167m-to-advance-mrna-biochip-based-manufacturing-platform
WEBMar 17, 2022 · Nutcracker Therapeutics, a biotech developing RNA therapeutics using its proprietary biochip-based manufacturing platform, has raised $167m in Series C financing: allowing it to expand and advance its pipeline of mRNA medicines for cancer and further refine its RNA manufacturing platform.
DA: 22 PA: 47 MOZ Rank: 56